The intracellular antibody capture technology (IACT): towards a consensus sequence for intracellular antibodies

Journal of Molecular Biology
Michela VisintinAntonino Cattaneo

Abstract

We describe the application of an intracellular antibody capture technology (IACT) as a generic in vivo selection procedure for isolating intracellular antibodies or ICAbs. IACT was applied to the de novo selection of functional ICAbs against the microtubule-associated protein TAU, found in neurofibrillary lesions of Alzheimer's disease brains. A panel of 17 different ICAbs was created which bind TAU inside cells and the epitopes recognized by the selected ICAbs have been determined by an in vivo epitope mapping procedure. Finally, sequence analysis showed that the IACT-derived ICAbs are characterized by a common signature of conserved amino acid residues, suggesting that the IACT naturally selects a sort of "captured consensus sequence" for intracellular antibodies. The development of IACT, together with the possibility of scaling up in a high throughput and automated format, makes IACT a new enabling tool for target validation in functional genomics and global proteomics.

Citations

Nov 17, 2007·Journal of Molecular Neuroscience : MN·Paola ZacchiEnrico Cherubini
Jan 7, 2003·Nature Medicine·Peter J Hudson, Christelle Souriau
May 29, 2007·Oncogene·I Zafir-LavieY Reiter
Feb 22, 2003·Nucleic Acids Research·Tomoyuki TanakaTerence H Rabbitts
Oct 3, 2008·Protein Engineering, Design & Selection : PEDS·Paola SeccoDaniele Sblattero
Apr 10, 2010·Protein Engineering, Design & Selection : PEDS·Erik KvamAnne Messer
Jan 14, 2012·Protein Engineering, Design & Selection : PEDS·Steven A JacobsKaryn T O'Neil
Dec 12, 2012·Protein Engineering, Design & Selection : PEDS·Janina SpeckKristian M Müller
Aug 24, 2010·BMC Biotechnology·Ole VielemeyerFranck Perez
Nov 24, 2007·BMC Biotechnology·Pascal PhilibertPierre Martineau
Nov 15, 2013·Clinical & Developmental Immunology·Kristen MarciniukScott Napper
Feb 16, 2005·Expert Opinion on Biological Therapy·Hilde RevetsSerge Muyldermans
Aug 6, 2009·Expert Opinion on Biological Therapy·Anne MesserDavid C Butler
May 5, 2007·Expert Opinion on Biological Therapy·John Doorbar, Heather Griffin
Mar 29, 2003·Expert Opinion on Biological Therapy·Christelle Souriau, Peter J Hudson
Aug 8, 2015·MAbs·Andrea L J MarschallThomas Böldicke
Sep 12, 2002·Expert Opinion on Therapeutic Targets·Michael JeffersHenri S Lichenstein
Mar 9, 2017·Protein Science : a Publication of the Protein Society·Thomas Böldicke
Apr 23, 2004·Trends in Immunology·Laura SanzLuis Alvarez-Vallina
Jul 21, 2004·Journal of Immunological Methods·Per-Ake Nygren, Arne Skerra
Aug 30, 2005·Protein Expression and Purification·Alessio LombardiPatrizia Galeffi
Jan 12, 2008·Journal of Molecular Biology·Tomoyuki Tanaka, Terence H Rabbitts
Dec 17, 2002·Nature Biotechnology·Stephen A JoblingMartine E Verhoeyen
Sep 28, 2017·Human Vaccines & Immunotherapeutics·Sarah B LloydWendy R Winnall
Sep 10, 2003·Yeast·Mirka ReinmanKristiina Takkinen
Feb 5, 2004·Chembiochem : a European Journal of Chemical Biology·Patrik ForrerAndreas Plückthun
Jul 20, 2007·Proteomics·Oda Stoevesandt, Michael J Taussig
May 23, 2009·British Journal of Pharmacology·Patrick ChamesDaniel Baty
Nov 11, 2003·Nature Biotechnology·Ahmet ZeytunAndrew R M Bradbury
Dec 21, 2005·Applied Microbiology and Biotechnology·Matthias Paschke
May 1, 2010·Expert Review of Clinical Pharmacology·Mark L DallasJim Deuchars
Jun 15, 2010·BioEssays : News and Reviews in Molecular, Cellular and Developmental Biology·David Pérez-MartínezTerence H Rabbitts
Oct 16, 2004·The Journal of General Virology·Fulvia VascottoOscar R Burrone
Nov 26, 2010·MAbs·Andrea L J MarschallStefan Dübel
Sep 7, 2002·The Journal of Biological Chemistry·Adrian Auf der MaurAlcide Barberis
Mar 23, 2006·Protein Engineering, Design & Selection : PEDS·Patrick AmstutzAndreas Plückthun
Feb 6, 2007·Protein Engineering, Design & Selection : PEDS·Mingha DaiAndrew R M Bradbury
Apr 18, 2020·BioDrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy·Congcong ZhangAndrea L J Marschall
Apr 21, 2007·Uirusu·Satoshi Komoto, Koki Taniguchi
Dec 29, 2009·Médecine sciences : M/S·Sandrine Moutel, Franck Perez

❮ Previous
Next ❯

Related Concepts

Related Feeds

Bacteriophage: Phage Therapy

Phage therapy uses bacterial viruses (bacteriophages) to treat bacterial infections and is widely being recognized as an alternative to antibiotics. Here is the latest research.

Antibody Specificity

Antibodies produced by B cells are highly specific for antigen as a result of random gene recombination and somatic hypermutation and affinity maturation. As the main effector of the humoral immune system, antibodies can neutralize foreign cells. Find the latest research on antibody specificity here.

Alzheimer's Disease: Tau & TDP-43

Alzheimer's disease is a neurodegenerative disease. This feed focuses on the underlying role of tau proteins and TAR DNA-binding protein 43, as well as other genetic factors, in Alzheimer's disease.